
Chiesi Farmaceutici
Europe, Emilia-Romagna, Italy, Parma
Description
Chiesi Farmaceutici provides research, development, production, and marketing of medicines for respiratory, neonatology, rare diseases.
Investor Profile
Chiesi Farmaceutici has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 33% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Private Equity, Post Ipo Debt rounds (top funding stages).
- Majority of deals are located in Canada, The Netherlands, United States.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Series B (33%)
- Private Equity (33%)
- Post Ipo Debt (33%)
Country Focus
- Canada (33%)
- The Netherlands (33%)
- United States (33%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Pharmaceutical
- Genetics
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Chiesi Farmaceutici frequently co-invest with?
Which angels does Chiesi Farmaceutici often collaborate with?
What are some of recent deals done by Chiesi Farmaceutici?
Find More Investors Like Chiesi Farmaceutici
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides





